Scott Gilbert has served pharmaceutical and biotech clients across a wide range of specialty and primary care therapeutic areas in both domestic and international markets.
Recent engagements have included pricing / managed markets strategy development, portfolio prioritization, medical adherence analysis, physician segmentation and opportunity analysis, and product forecasting. He has extensive expertise in advanced quantitative analyses (quantitative primary research, medical claims analysis, forecasting / scenario modeling) and has worked in a number of therapeutic areas including asthma, osteoporosis, cardiovascular, oncology / hematology, neuroscience, immunology, HIV, hospital anti-infectives, transplantation, and dermatology. Scott joined Putnam in 2004 after graduating from Dartmouth College with a B.A. in Biology with a focus on Economics.